SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-037643
Filing Date
2022-07-06
Accepted
2022-07-06 16:35:17
Documents
13
Period of Report
2022-07-06
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea162506-8k_aikido.htm   iXBRL 8-K 30084
2 LETTER OF WITHUMSMITH+BROWN, PC, TO THE SECURITIES AND EXCHANGE COMMISSION DATED ea162506ex16-1_aikido.htm EX-16.1 1942
  Complete submission text file 0001213900-22-037643.txt   206322

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE aiki-20220706.xsd EX-101.SCH 2980
4 XBRL LABEL FILE aiki-20220706_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE aiki-20220706_pre.xml EX-101.PRE 22373
7 EXTRACTED XBRL INSTANCE DOCUMENT ea162506-8k_aikido_htm.xml XML 3606
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 221069223
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services